nifedipine has been researched along with Ischemia in 50 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The effects of intraarterially infused nifedipine, reactive hyperemia after 10 min arterial occlusion combined with handgrip exercise and local heating, and arterial occlusion combined with nifedipine on forearm blood flow and blood pressure were investigated in random order." | 9.06 | Effects of reactive hyperemia and nifedipine on forearm vascular resistance in essential hypertension: evidence for functional abnormality. ( Braun, J; Distler, A; Gotzen, R; Meyer-Sabellek, W; Schulte, KL, 1987) |
| " Nifedipine ameliorated obesity-impaired revascularization through suppressing oxidative stress and enhancing the number of EPCs." | 7.78 | Nifedipine ameliorates ischemia-induced revascularization in diet-induced obese mice. ( Ishii, M; Kito, T; Kondo, M; Murohara, T; Shibata, R; Suzuki, H; Yamamoto, T, 2012) |
| "The first case of intestinal infarction associated with nifedipine overdose is presented." | 7.69 | Intestinal infarction due to nifedipine overdose. ( Wax, PM, 1995) |
| " Nilvadipine (FK 235, FR 34235) suppressed ischemia (20 min)-reflow (20 min)-induced paw edema of mice (ED30:0." | 7.68 | Inhibition by nilvadipine of ischemic and carrageenan paw edema as well as of superoxide radical production from neutrophils and xanthine oxidase. ( Oyanagui, Y; Sato, S, 1991) |
| "We have presented a case in which nifedipine-induced hypotension in a patient receiving beta blocker and nitrate therapy precipitated mesenteric angina, leading to emergency exploratory celiotomy." | 7.67 | Nifedipine-induced hypotension and mesenteric ischemia. ( Deppe, SA; Elliott, BM; Goglin, WK, 1989) |
| "To determine the effects of Nifedipine on cold stress reactive hyperemia in patients with Raynaud's phenomenon." | 7.67 | [Action of nifedipine on the post-ischemic cold hyperemia reaction in Raynaud's phenomenon]. ( Baudot, N; Blaison, N; Evenou, P; Gilard, M; Mathieu, JF; Vayssairat, M, 1989) |
| "This study was undertaken in order to determine whether the administration of nifedipine, a calcium channel blocker, could protect the liver from ischemic damage and to investigate its effect on the hepatic cellular energy status and cardio-vascular system after 60 minutes of hepatic ischemia in dogs." | 7.67 | The effect of nifedipine, a calcium channel blocker, on liver ischemia in dogs. ( Ishimaru, M; Kawano, N; Morioka, Y; Nagao, T; Sodeyama, M; Yoshimi, F, 1988) |
| "A 39-year-old woman suffering from migraine took two suppositories of an ergotamine-containing proprietary drug (Cafergot, containing 2 mg ergotamine tartrate) for the first time again after an abstinence of two years." | 5.28 | [Extremity-threatening ischemia in ergotism. Successful treatment with the intra-arterial administration of nifedipine]. ( Brandt, J; Ernst, R; Mumme, A; Schäfer, K; Zumtobel, V, 1991) |
| " The effects of intraarterially infused nifedipine, reactive hyperemia after 10 min arterial occlusion combined with handgrip exercise and local heating, and arterial occlusion combined with nifedipine on forearm blood flow and blood pressure were investigated in random order." | 5.06 | Effects of reactive hyperemia and nifedipine on forearm vascular resistance in essential hypertension: evidence for functional abnormality. ( Braun, J; Distler, A; Gotzen, R; Meyer-Sabellek, W; Schulte, KL, 1987) |
| " We present the case of limb ischemia secondary to accidental intra-arterial buprenorphine/naloxone film injection successfully treated with sublingual nitroglycerin." | 3.96 | Use of Sublingual Nitrates for Management of Limb Ischemia Secondary to Inadvertent Intra-Arterial Buprenorphine/Naloxone (Suboxone®) Film Injection. ( Franqui-Rivera, H; Gonzalez-Cordero, A; Reyes, M; Rivera-Gonzalez, J, 2020) |
| " Nifedipine ameliorated obesity-impaired revascularization through suppressing oxidative stress and enhancing the number of EPCs." | 3.78 | Nifedipine ameliorates ischemia-induced revascularization in diet-induced obese mice. ( Ishii, M; Kito, T; Kondo, M; Murohara, T; Shibata, R; Suzuki, H; Yamamoto, T, 2012) |
| " We tested the hypothesis that nifedipine can prevent ischemia-induced endothelial permeability increases by inhibiting protein kinase C (PKC) in cultured porcine endothelial cells." | 3.70 | Calcium antagonists ameliorate ischemia-induced endothelial cell permeability by inhibiting protein kinase C. ( Bychkov, R; Haller, H; Hempel, A; Lindschau, C; Luft, FC; Maasch, C; Mahn, M; Noll, T, 1999) |
| "The first case of intestinal infarction associated with nifedipine overdose is presented." | 3.69 | Intestinal infarction due to nifedipine overdose. ( Wax, PM, 1995) |
| "In order to evaluate the role of nifedipine in the nephrotoxic effect induced by both ischemia and CyA, 18 healthy mongrel dogs were used." | 3.68 | Reduction of CyA nephrotoxicity by nifedipine during and after experimental in situ renal preservation. ( Alivanis, P; Bougioukas, G; Grekas, D; Kalekou, H; Pyrpasopoulos, M; Tourkantonis, A, 1992) |
| " Nilvadipine (FK 235, FR 34235) suppressed ischemia (20 min)-reflow (20 min)-induced paw edema of mice (ED30:0." | 3.68 | Inhibition by nilvadipine of ischemic and carrageenan paw edema as well as of superoxide radical production from neutrophils and xanthine oxidase. ( Oyanagui, Y; Sato, S, 1991) |
| "We have presented a case in which nifedipine-induced hypotension in a patient receiving beta blocker and nitrate therapy precipitated mesenteric angina, leading to emergency exploratory celiotomy." | 3.67 | Nifedipine-induced hypotension and mesenteric ischemia. ( Deppe, SA; Elliott, BM; Goglin, WK, 1989) |
| "To determine the effects of Nifedipine on cold stress reactive hyperemia in patients with Raynaud's phenomenon." | 3.67 | [Action of nifedipine on the post-ischemic cold hyperemia reaction in Raynaud's phenomenon]. ( Baudot, N; Blaison, N; Evenou, P; Gilard, M; Mathieu, JF; Vayssairat, M, 1989) |
| "This study was undertaken in order to determine whether the administration of nifedipine, a calcium channel blocker, could protect the liver from ischemic damage and to investigate its effect on the hepatic cellular energy status and cardio-vascular system after 60 minutes of hepatic ischemia in dogs." | 3.67 | The effect of nifedipine, a calcium channel blocker, on liver ischemia in dogs. ( Ishimaru, M; Kawano, N; Morioka, Y; Nagao, T; Sodeyama, M; Yoshimi, F, 1988) |
| " The effect size may have been small because of low dosing in studies." | 2.43 | Calcium channel blockers for primary Raynaud's phenomenon: a meta-analysis. ( Pope, JE; Thompson, AE, 2005) |
| "Both drugs are used to treat hypertension, but only verapamil can be used to produce atrioventricular block in patients with atrial fibrillation." | 2.43 | Mechanism of tissue-selective drug action in the cardiovascular system. ( Barrett, TD; Maurice, DH; Triggle, DJ; Walker, MJ, 2005) |
| "Hypertension that complicates preeclampsia in pregnancy is a disorder that requires special consideration in both prevention and pharmacologic treatment." | 2.43 | Pathophysiology and medical management of systemic hypertension in preeclampsia. ( Frishman, WH; Schlocker, SJ; Tejani, N; Veresh, M, 2006) |
| "A 39-year-old woman suffering from migraine took two suppositories of an ergotamine-containing proprietary drug (Cafergot, containing 2 mg ergotamine tartrate) for the first time again after an abstinence of two years." | 1.28 | [Extremity-threatening ischemia in ergotism. Successful treatment with the intra-arterial administration of nifedipine]. ( Brandt, J; Ernst, R; Mumme, A; Schäfer, K; Zumtobel, V, 1991) |
| "Verapamil was the only calcium-blocking drug which attenuated the post-ischaemic renal dysfunction." | 1.27 | Variable results of calcium blockade in post-ischaemic renal failure. ( Fitzpatrick, JM; Leahy, AL; Wait, RB, 1988) |
| "Nisoldipine treatment resulted in the survival of all animals (compared to 66." | 1.27 | Calcium channel blocker nisoldipine limits ischemic damage in rat kidney. ( Garthoff, B; Hertle, L, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (44.00) | 18.7374 |
| 1990's | 11 (22.00) | 18.2507 |
| 2000's | 10 (20.00) | 29.6817 |
| 2010's | 3 (6.00) | 24.3611 |
| 2020's | 4 (8.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peng, C | 1 |
| Yang, LJ | 1 |
| Zhang, C | 1 |
| Jiang, Y | 1 |
| Shang, LW | 1 |
| He, JB | 1 |
| Zhou, ZW | 1 |
| Tao, X | 1 |
| Tie, L | 1 |
| Chen, AF | 1 |
| Xie, HH | 1 |
| Varghese, B | 1 |
| Chew, E | 1 |
| Konig, MF | 1 |
| Rivera-Gonzalez, J | 1 |
| Gonzalez-Cordero, A | 1 |
| Reyes, M | 1 |
| Franqui-Rivera, H | 1 |
| Du, C | 1 |
| Volkow, ND | 1 |
| You, J | 1 |
| Park, K | 1 |
| Allen, CP | 1 |
| Koob, GF | 1 |
| Pan, Y | 1 |
| Fukunaga, Y | 1 |
| Izawa-Ishizawa, Y | 1 |
| Horinouchi, Y | 1 |
| Sairyo, E | 1 |
| Ikeda, Y | 1 |
| Ishizawa, K | 1 |
| Tsuchiya, K | 1 |
| Abe, Y | 1 |
| Hashimoto, I | 1 |
| Tamaki, T | 1 |
| Jiang, W | 1 |
| Kirkup, AJ | 1 |
| Grundy, D | 1 |
| Kito, T | 1 |
| Shibata, R | 1 |
| Kondo, M | 1 |
| Yamamoto, T | 1 |
| Suzuki, H | 1 |
| Ishii, M | 1 |
| Murohara, T | 1 |
| Nakai, A | 1 |
| Taniuchi, Y | 1 |
| Oya, A | 1 |
| Asakura, H | 1 |
| Koshino, T | 1 |
| Araki, T | 1 |
| Hauser, D | 1 |
| Pokroy, R | 1 |
| Bukelman, A | 1 |
| Katz, H | 1 |
| Pollack, A | 1 |
| Thompson, AE | 1 |
| Pope, JE | 1 |
| Barrett, TD | 1 |
| Triggle, DJ | 1 |
| Walker, MJ | 1 |
| Maurice, DH | 1 |
| Fomin, VV | 1 |
| Safonov, VV | 1 |
| Kozlovskaia, NL | 1 |
| Moiseev, SV | 1 |
| Osipenko, VI | 1 |
| Tironishvili, OI | 1 |
| Naz, I | 1 |
| Sophie, Z | 1 |
| Frishman, WH | 1 |
| Veresh, M | 1 |
| Schlocker, SJ | 1 |
| Tejani, N | 1 |
| Ertem, K | 1 |
| Pitlik, S | 1 |
| Manor, RS | 1 |
| Lipshitz, I | 1 |
| Perry, G | 1 |
| Rosenfeld, J | 1 |
| Frampton, MW | 1 |
| Kemerer, VF | 1 |
| Dagher, FJ | 2 |
| Pais, SO | 2 |
| Buxton, AE | 1 |
| Hirshfeld, JW | 1 |
| Untereker, WJ | 1 |
| Goldberg, S | 1 |
| Harken, AH | 1 |
| Stephenson, LW | 1 |
| Edie, RN | 1 |
| Tauskela, JS | 1 |
| Shoubridge, EA | 1 |
| Wax, PM | 1 |
| Marni, A | 1 |
| Forti, D | 1 |
| Calvillo, L | 1 |
| Gaja, G | 1 |
| Ferrero, ME | 1 |
| Hempel, A | 1 |
| Lindschau, C | 1 |
| Maasch, C | 1 |
| Mahn, M | 1 |
| Bychkov, R | 1 |
| Noll, T | 1 |
| Luft, FC | 1 |
| Haller, H | 1 |
| Eckert, RE | 1 |
| Karsten, AJ | 1 |
| Utz, J | 1 |
| Ziegler, M | 1 |
| Kubo, T | 1 |
| Yokoi, T | 1 |
| Hagiwara, Y | 1 |
| Fukumori, R | 1 |
| Goshima, Y | 1 |
| Misu, Y | 1 |
| Takeda, K | 1 |
| Nakagawa, Y | 1 |
| Katono, Y | 1 |
| Imai, S | 1 |
| Alivanis, P | 1 |
| Grekas, D | 1 |
| Bougioukas, G | 1 |
| Kalekou, H | 1 |
| Pyrpasopoulos, M | 1 |
| Tourkantonis, A | 1 |
| Oyanagui, Y | 1 |
| Sato, S | 1 |
| Prünte-Glowazki, A | 1 |
| Flammer, J | 1 |
| Mumme, A | 1 |
| Ernst, R | 1 |
| Brandt, J | 1 |
| Schäfer, K | 1 |
| Zumtobel, V | 1 |
| Crosson, CE | 1 |
| Willis, JA | 1 |
| Potter, DE | 1 |
| Karasawa, A | 1 |
| Kubo, K | 1 |
| Weselcouch, EO | 1 |
| Demusz, CD | 1 |
| Schulte, KL | 1 |
| Braun, J | 1 |
| Meyer-Sabellek, W | 1 |
| Gotzen, R | 1 |
| Distler, A | 1 |
| Goglin, WK | 1 |
| Elliott, BM | 1 |
| Deppe, SA | 1 |
| Vayssairat, M | 1 |
| Blaison, N | 1 |
| Baudot, N | 1 |
| Evenou, P | 1 |
| Gilard, M | 1 |
| Mathieu, JF | 1 |
| Beykirch, H | 1 |
| Reuter, W | 1 |
| Voigt, H | 1 |
| Herrmann, W | 1 |
| Hall, ED | 1 |
| Wolf, DL | 1 |
| Bratell, S | 1 |
| Folmerz, P | 1 |
| Hansson, R | 1 |
| Jonsson, O | 1 |
| Lundstam, S | 1 |
| Pettersson, S | 1 |
| Rippe, B | 1 |
| Scherstén, T | 1 |
| Kazda, S | 1 |
| Hirth, C | 1 |
| Bulling, M | 1 |
| Burns, R | 1 |
| Leahy, AL | 1 |
| Fitzpatrick, JM | 1 |
| Wait, RB | 1 |
| Yoshimi, F | 1 |
| Ishimaru, M | 1 |
| Sodeyama, M | 1 |
| Nagao, T | 1 |
| Kawano, N | 1 |
| Morioka, Y | 1 |
| Morgan, RH | 1 |
| Psaila, JV | 1 |
| Lewis, P | 1 |
| Davies, WT | 1 |
| Woodcock, JP | 1 |
| Cheung, JY | 1 |
| Bonventre, JV | 1 |
| Malis, CD | 1 |
| Leaf, A | 1 |
| Offermann, W | 1 |
| Kuhn, W | 1 |
| Soboll, S | 1 |
| Ishikawa, T | 1 |
| Leibfritz, D | 1 |
| Richards, W | 1 |
| Queral, LA | 1 |
| Hertle, L | 1 |
| Garthoff, B | 1 |
| Antón Aranda, E | 1 |
| Pizarro, M | 1 |
| Maraví Petri, E | 1 |
| Baker, GL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Identification of Transient Receptor Potential (TRP) Channels as New Potential Therapeutic Targets in Primary and Secondary Raynaud's Phenomenon.[NCT03211325] | 29 participants (Actual) | Interventional | 2016-10-18 | Completed | |||
| A Randomized, Single-blinded Placebo-controlled Trial of Ischemic Preconditioning in Raynaud's Phenomenon (RP)[NCT02506062] | 21 participants (Actual) | Interventional | 2015-07-31 | Completed | |||
| The Effects of Anti-oxidants on Clinical Outcomes and Radiological Features of Chronic Spinal Cord Injury: A Pilot Study[NCT01904591] | 4 participants (Actual) | Interventional | 2013-10-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for nifedipine and Ischemia
| Article | Year |
|---|---|
Calcium channel blockers for primary Raynaud's phenomenon: a meta-analysis.
Topics: Calcium Channel Blockers; Humans; Ischemia; Nifedipine; Randomized Controlled Trials as Topic; Rayna | 2005 |
Calcium channel blockers for primary Raynaud's phenomenon: a meta-analysis.
Topics: Calcium Channel Blockers; Humans; Ischemia; Nifedipine; Randomized Controlled Trials as Topic; Rayna | 2005 |
Calcium channel blockers for primary Raynaud's phenomenon: a meta-analysis.
Topics: Calcium Channel Blockers; Humans; Ischemia; Nifedipine; Randomized Controlled Trials as Topic; Rayna | 2005 |
Calcium channel blockers for primary Raynaud's phenomenon: a meta-analysis.
Topics: Calcium Channel Blockers; Humans; Ischemia; Nifedipine; Randomized Controlled Trials as Topic; Rayna | 2005 |
Mechanism of tissue-selective drug action in the cardiovascular system.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Binding Sites; Calcium Channels; Cardiovascular System; Chemist | 2005 |
Pathophysiology and medical management of systemic hypertension in preeclampsia.
Topics: Adrenergic beta-Antagonists; Aspirin; Calcium; Calcium Channel Blockers; Cerebral Hemorrhage; Female | 2006 |
Tissue protection by nifedipine and its calcium antagonistic derivatives in vascular damage.
Topics: Humans; Ischemia; Muscle, Smooth, Vascular; Nifedipine | 1987 |
Calcium and ischemic injury.
Topics: Animals; Calcium; Calcium Channel Blockers; Chlorpromazine; Cytosol; Extracellular Space; Homeostasi | 1986 |
1 trial available for nifedipine and Ischemia
| Article | Year |
|---|---|
Effects of reactive hyperemia and nifedipine on forearm vascular resistance in essential hypertension: evidence for functional abnormality.
Topics: Adult; Blood Flow Velocity; Blood Pressure; Forearm; Humans; Hyperemia; Hypertension; Ischemia; Male | 1987 |
44 other studies available for nifedipine and Ischemia
| Article | Year |
|---|---|
Low-dose nifedipine rescues impaired endothelial progenitor cell-mediated angiogenesis in diabetic mice.
Topics: Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Endothelial Progenitor Cells; Glucose; Is | 2023 |
Digit Ulcerations in a Young Woman.
Topics: Female; Fingers; Humans; Ischemia; Nifedipine; Photography; Raynaud Disease; Scleroderma, Systemic; | 2020 |
Use of Sublingual Nitrates for Management of Limb Ischemia Secondary to Inadvertent Intra-Arterial Buprenorphine/Naloxone (Suboxone®) Film Injection.
Topics: Administration, Sublingual; Adult; Angiography; Anticoagulants; Buprenorphine, Naloxone Drug Combina | 2020 |
Cocaine-induced ischemia in prefrontal cortex is associated with escalation of cocaine intake in rodents.
Topics: Animals; Cocaine; Cocaine-Related Disorders; Drug-Seeking Behavior; Ischemia; Male; Mice; Nifedipine | 2020 |
Topical application of nitrosonifedipine, a novel radical scavenger, ameliorates ischemic skin flap necrosis in a mouse model.
Topics: Administration, Topical; Animals; Antioxidants; Blotting, Western; Disease Models, Animal; Graft Sur | 2017 |
Mast cells drive mesenteric afferent signalling during acute intestinal ischaemia.
Topics: Animals; Calcium Channels, L-Type; Gastrointestinal Motility; Hexamethonium; Intestines; Ischemia; M | 2011 |
Nifedipine ameliorates ischemia-induced revascularization in diet-induced obese mice.
Topics: Animals; Calcium Channel Blockers; Capillaries; Dietary Carbohydrates; Dietary Fats; Endothelial Cel | 2012 |
Windows of therapeutic opportunity on fetal growth retardation induced by transient intrauterine ischemia in rats.
Topics: Animals; Cyclic N-Oxides; Dizocilpine Maleate; Female; Fetal Growth Retardation; Fetal Hypoxia; Isch | 2002 |
Ocular ischemia associated with uncontrolled hypertension in lupus erythematosus.
Topics: Adult; Blood Pressure; Fluorescein Angiography; Humans; Hypertension; Ischemia; Lupus Erythematosus, | 2004 |
[Ischemic disease of the kidneys in a patient with morbid obesity: characteristics of the course and diagnostic policy].
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Diagnosis, Differential; Health Policy; Human | 2006 |
Acute limb ischemia due to ergotism.
Topics: Acute Disease; Adult; Amputation, Surgical; Ergotism; Female; Gangrene; Hand; Humans; Ischemia; Midd | 2006 |
Prolonged transient hand ischaemia secondary to a penicillin skin test.
Topics: Aspirin; Calcium Channel Blockers; Cyanosis; Drug Hypersensitivity; Drug Therapy, Combination; Fibri | 2007 |
Transient retinal ischaemia induced by nifedipine.
Topics: Aged; Angina Pectoris; Humans; Ischemia; Male; Nifedipine; Retinal Vessels; Visual Fields | 1983 |
Lower extremity ischemia associated with use of military antishock trousers.
Topics: Blood Pressure; Gravity Suits; Humans; Hypotension; Ischemia; Leg; Male; Middle Aged; Nifedipine | 1984 |
Successful treatment of ergotism with nifedipine.
Topics: Angiography; Aortography; Caffeine; Drug Combinations; Ergotamine; Ergotism; Female; Humans; Ischemi | 1984 |
Perioperative coronary arterial spasm: long-term follow-up.
Topics: Adult; Aged; Cardiac Catheterization; Cardiac Output, Low; Coronary Angiography; Coronary Artery Byp | 1982 |
Intracellular calcium dynamics and cellular energetics in ischemic NG108-15 cells studied by concurrent 31P/19F and 23Na double-quantum filtered NMR spectroscopy.
Topics: Biological Transport; Calcium; Calcium Channel Blockers; Calcium Channels; Cell Compartmentation; Ce | 1996 |
Intestinal infarction due to nifedipine overdose.
Topics: Abdomen, Acute; Adult; Calcium Channel Blockers; Fatal Outcome; Humans; Infarction; Intestines; Isch | 1995 |
Anti-ischemic effect of oligotide treatment in rat kidney: comparison with the effect of nifedipine and isosorbide dinitrate.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Cyclic AMP; Energy | 1996 |
Calcium antagonists ameliorate ischemia-induced endothelial cell permeability by inhibiting protein kinase C.
Topics: Animals; Calcium Channel Blockers; Capillary Permeability; Cells, Cultured; Endothelium, Vascular; I | 1999 |
Regulation of renal artery smooth muscle tone by alpha1-adrenoceptors: role of voltage-gated calcium channels and intracellular calcium stores.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Calcium; Calcium Channel Blockers; | 2000 |
Characteristics of protective effects of NMDA antagonist and calcium channel antagonist on ischemic calcium accumulation in rat hippocampal CA1 region.
Topics: Animals; Calcium; Calcium Channel Blockers; Cell Hypoxia; Dizocilpine Maleate; Excitatory Amino Acid | 2001 |
Effects of coronary vasodilators on large and small coronary arteries of dogs.
Topics: Adenosine; Animals; Arteries; Coronary Circulation; Coronary Vessels; Dipyridamole; Dogs; Erythritol | 1977 |
Reduction of CyA nephrotoxicity by nifedipine during and after experimental in situ renal preservation.
Topics: Animals; Cyclosporine; Dogs; Drug Interactions; Ischemia; Kidney; Nifedipine; Organ Preservation; Pe | 1992 |
Inhibition by nilvadipine of ischemic and carrageenan paw edema as well as of superoxide radical production from neutrophils and xanthine oxidase.
Topics: Animals; Calcimycin; Carrageenan; Edema; Free Radicals; Ischemia; L-Lactate Dehydrogenase; Male; Mic | 1991 |
[Ocular vasospasm. 4: Clinical examples].
Topics: Adult; Arousal; Capillaries; Cold Temperature; Eye; Female; Glaucoma; Humans; Ischemia; Male; Middle | 1991 |
[Extremity-threatening ischemia in ergotism. Successful treatment with the intra-arterial administration of nifedipine].
Topics: Acute Disease; Adult; Arm; Caffeine; Drug Combinations; Ergotamine; Ergotism; Female; Humans; Infusi | 1991 |
Effect of the calcium antagonist, nifedipine, on ischemic retinal dysfunction.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Electroretinography; Female; Isch | 1990 |
Protection by benidipine hydrochloride (KW-3049), a calcium antagonist, of ischemic kidney in rats via inhibitions of Ca-overload, ATP-decline and lipid peroxidation.
Topics: Adenosine Triphosphate; Animals; Blood Urea Nitrogen; Calcium; Calcium Channel Blockers; Creatinine; | 1990 |
Drug effects on function in the ferret ischemic hindlimb.
Topics: Animals; Blood Pressure; Dose-Response Relationship, Drug; Electric Stimulation; Ferrets; Hindlimb; | 1990 |
Nifedipine-induced hypotension and mesenteric ischemia.
Topics: Adrenergic beta-Antagonists; Calcium Chloride; Drug Therapy, Combination; Hemodynamics; Humans; Hypo | 1989 |
[Action of nifedipine on the post-ischemic cold hyperemia reaction in Raynaud's phenomenon].
Topics: Adult; Cold Temperature; Female; Humans; Hyperemia; Ischemia; Male; Middle Aged; Nifedipine; Raynaud | 1989 |
[Lipid metabolism and peripheral hemodynamics in arteriosclerosis obliterans treated with nifedipine--a comparison with pentoxifylline].
Topics: Arteriosclerosis Obliterans; Hemodynamics; Humans; Ischemia; Leg; Lipids; Male; Middle Aged; Nifedip | 1989 |
A pharmacological analysis of the pathophysiological mechanisms of posttraumatic spinal cord ischemia.
Topics: Animals; Benzofurans; Calcium Channel Blockers; Cats; Cyclooxygenase Inhibitors; Diltiazem; Dinopros | 1986 |
Effects of oxygen free radical scavengers, xanthine oxidase inhibition and calcium entry-blockers on leakage of albumin after ischaemia. An experimental study in rabbit kidneys.
Topics: Allopurinol; Animals; Calcium Channel Blockers; Capillary Permeability; Catalase; Felodipine; Free R | 1988 |
Occipital cortical "angina" induced by nifedipine.
Topics: Aged; Humans; Ischemia; Male; Nifedipine; Occipital Lobe; Physical Exertion; Visual Acuity | 1988 |
Variable results of calcium blockade in post-ischaemic renal failure.
Topics: Acute Kidney Injury; Animals; Calcium Channel Blockers; Flunarizine; Ischemia; Kidney; Male; Nifedip | 1988 |
The effect of nifedipine, a calcium channel blocker, on liver ischemia in dogs.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Dogs; Injections, Intravenous; Ischemia; | 1988 |
The effects of nifedipine on blood flow in peripheral vascular disease of the lower limbs.
Topics: Administration, Sublingual; Aged; Blood Flow Velocity; Blood Pressure; Female; Femoral Artery; Human | 1987 |
The in vivo contour plot. An improved representation of stimulus experiments.
Topics: Animals; Coronary Circulation; Heart; Hypoxia; Ischemia; Liver; Magnetic Resonance Spectroscopy; Mic | 1987 |
Severe unilateral ischemia of the lower extremity caused by ergotamine: treatment with nifedipine.
Topics: Aortography; Ergotamine; Female; Humans; Ischemia; Leg; Middle Aged; Nifedipine; Suppositories; Ultr | 1985 |
Calcium channel blocker nisoldipine limits ischemic damage in rat kidney.
Topics: Animals; Calcium Channel Blockers; Ischemia; Kidney; Male; Nifedipine; Nisoldipine; Rats; Rats, Inbr | 1985 |
[Treatment of peripheral ischemia secondary to ergotism with nifedipine].
Topics: Adult; Ergotism; Female; Humans; Ischemia; Leg; Nifedipine | 1985 |
The hypothenar hammer syndrome.
Topics: Finger Injuries; Fingers; Humans; Ischemia; Male; Middle Aged; Nifedipine; Syndrome | 1985 |